Clover Biopharmaceuticals, Ltd. (02197.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.9x

Market Cap

HKD 2.65B

MomentumView details →

1D Return

+3.96%

YTD Return

−10.26%

RSI (14)

48.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.9x

Market Cap

HKD 2.65B

RSI (14)

48.9

MomentumView details →

1D Return

+3.96%

YTD Return

−10.26%

ProfitabilityView details →

Gross Margin

−1337.09%

Net Margin

−127.01%

EBITDA Margin

−2159.27%

ROE (TTM)

8.28%

ROA (TTM)

−27.42%

Asset Turnover

0.15x

GrowthView details →

Revenue YoY

+79.03%

EPS YoY

+95.62%

FCF YoY

+84.09%

Revenue CAGR 3Y

−70.51%

EPS CAGR 3Y

+77.78%

EBITDA YoY

+71.68%

EarningsView details →

EPS (Actual)

HKD 0.86

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−0.00x

Current Ratio

0.73x

Quick Ratio

0.71x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

52.20M

Net Income (TTM)

−66.30M

Op. CF (TTM)

−326.23M

Next earningsMar 30, 2027 →

Latest newsMore news →

Clover Biopharmaceuticals reported interim results for the six months ended June 2026, turning a profit of 955 million yuan from a loss of 101 million yuan a year earlier, mainly due to a one-time accounting gain of about 1.087 billion yuan from the GAVI settlement agreement.10d ago

Similar companies

Frontage Holdings Corporation01521.HK Beijing Luzhu Biotechnology Co., Ltd.02480.HK Viridian Therapeutics, Inc.VRDN Nurix Therapeutics, Inc.NRIX Vera Therapeutics, Inc.VERA BioDlink International Company Limited01875.HK Find similar companies →

Latest newsMore news →

Clover Biopharmaceuticals reported interim results for the six months ended June 2026, turning a profit of 955 million yuan from a loss of 101 million yuan a year earlier, mainly due to a one-time accounting gain of about 1.087 billion yuan from the GAVI settlement agreement.10d ago